Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
MIC-B12 has a documented safety profile in the clinical literature, though common side effects, warnings, and contraindications vary by formulation
Developed by researchers in Australia, AOD-9604 was initially investigated as a potential anti-obesity drug due to its ability to stimulate lipolysis (fat breakdown) and inhibit lipogenesis (fat accumulation)
Solid Phase Peptide Synthesis
Additionally, B12 helps lower homocysteine levels, which may reduce the risk of heart disease, heart attacks, and strokes
By modulating NNMT activity in experimental systems, researchers evaluate downstream shifts in methyl donor utilization, enzymatic output, and pathway-level signaling
US$ 21.18
US$ 20.79
US$ 29.88
US$ 25.00
